Project Grant HT94252410829
- This $653,317 Project Grant award from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports the development of a novel graft-localized drug delivery platform at Wake Forest University Health Sciences (WFUHS). The funding will be used to conduct research aimed at attenuating innate inflammation and optimizing immunosuppression in vascularized composite allotransplantation over a 2-year period from September 2024 to September 2026. WFUHS, a leading...
- This $299,999 Project Grant award was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) federal grant program. The grant supports research conducted by Wake Forest University Health Sciences (WFUHS) to develop microparticle delivery of chemokine muteins for guiding chemokine receptor engineered regulatory T cells (Tregs) to induce tolerance after vascular composite allograft transplants. The research project aims to advance therapeutic...
- Federal Project Grant Award Summary Wake Forest University Health Sciences received a $770,000 Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) awarded on September 15, 2025, with a completion date of September 14, 2028. The award supports the development and advancement of biocompatible cryopreservation techniques for eyelid and periorbital tissues, research being conducted at the institution's Winston-Salem, North...
- Federal Project Grant Award Summary Wake Forest University Health Sciences received a $2.47 million Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420), awarded September 30, 2025, with a completion date of September 29, 2029. The project, titled "Allograft vs. Autograft to Improve Timely Return to Duty Following Nonunion," supports advanced biomedical research addressing critical health challenges relevant to...
- Federal Project Grant Award Summary Wake Forest University Health Sciences received a $1.48 million Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) awarded on September 30, 2025, with an ultimate completion date of September 29, 2029. The grant supports the Intraosseous Antibiotics for Osseointegration (IOAOI) research initiative, which investigates advanced antibiotic delivery mechanisms to enhance bone integration and...
- Federal Grant Award Summary Wake Forest University Health Sciences received a $1.79 million Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420), awarded October 1, 2025, with a completion date of September 30, 2028. The award funds research into PEDF (Pigment Epithelium-Derived Factor)-enriched exosomes for improving urethral sphincter function following radical prostatectomy. This three-year initiative represents the DHA's...
- Federal Grant Award Summary Wake Forest University Health Sciences received a $810,171 Project Grant award from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) with an award date of September 1, 2025, and an ultimate completion date of August 31, 2028. The grant supports research investigating the therapeutic effects of peroxisome proliferator-activated receptor alpha (PPAR-α) agonists on combat-induced proliferative vitreoretinopathy, an...
- Federal Grant Award Summary Wake Forest University Health Sciences received a $2.2 million Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420), awarded November 1, 2025, with completion scheduled for October 31, 2029. The award supports the SEXTANT Study, which evaluates a new strategy for protocolized antibiotic care in severe open fractures. This research initiative addresses a critical military medical need by developing...
- This $1,189,653 Project Grant was awarded by the Defense Health Agency to Wake Forest University Health Sciences on August 1, 2023 under the Military Medical Research and Development program (CFDA 12.420). The purpose of the grant is to develop a stable and effective off-the-shelf wound care treatment for combat burn injuries. Wake Forest University Health Sciences, an academic medical center, will conduct the research and development work over a 3-year period ending on July 31, 2026. As a...
- This federal Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) provides $2,477,108 to Wake Forest University Health Sciences to conduct research on single-implant versus dual-implant fixation of distal femur extra-articular and complete articular fractures. The project will run from September 30, 2023 through September 29, 2027. Wake Forest University Health Sciences, an academic medical center, will lead this research...
This federal Project Grant award of $799,999.00 was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The award supports the "RESUSCITATION BY ENDOTHELIAL STABILIZATION AND TARGETED OXYGEN RESCUE (RESTOR) PLATFORM FOR VASCULARIZED COMPOSITE ALLOTRANSPLANTATION" research project at Wake Forest University Health Sciences (WFUHS), a leading academic medical center and research institution. The goal of this project is to develop an advanced medical platform for vascularized composite allotransplantation, which has the potential to transform healthcare for military service members and the broader public. WFUHS has demonstrated significant capabilities in executing complex federal contract and grant awards, including advanced medical training, injury research, and specialized medical technology development for various government agencies. This award, with a performance period from August 1, 2024 to July 31, 2026, will enable WFUHS to advance its research in this critical area of vascularized composite allotransplantation.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $800.0k | 7/26/24 |